Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Becton Dickinson (BDX) shares

Learn how to easily invest in Becton Dickinson shares.

Becton Dickinson and Company (BDX) is a leading medical instruments & supplies business based in the US. It opened the day at USD$253.22 after a previous close of USD$253.82. During the day the price has varied from a low of USD$252.47 to a high of USD$254.61. The latest price was USD$253.18 (25 minute delay). Becton Dickinson is listed on the NYSE and employs 75,000 staff. All prices are listed in US Dollars.

How to buy shares in Becton Dickinson

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Compare share trading platforms

Name Product Available Investment Types Min. Monthly Fee Available Markets
OFFER
BlackBull Markets Share Trading
Shares
$0
US, NZ, AU, Funds with exposure to multiple markets
Exclusive: Sign up through Finder and get 5 free shares with a minimum first time deposit of $1,000. T&Cs apply.
Trade 23,000+ shares and access 80+ global markets across the US, New Zealand, Australia and more, plus benefit from extended trading hours, no monthly fees, 24/6 dedicated local support and a mobile trading app available on both Android and iOS.
OFFER
Hatch
Shares, ETFs
$0
US
Sign up to Hatch through Finder and get a $20 top-up when you deposit $100 or more.
Invest in more than 4,700 US companies and over 1,200 exchange-traded funds (ETFs) - no minimum investment or monthly fees.
Rockfort Markets Share Trading
Rockfort Markets Share Trading
Shares
$20
US, AU, Funds with exposure to multiple markets
Trade shares in more than 1000 companies across the US, Australia and more.
Low brokerage on trades, plus access to professional tools, research and live market data. Available on desktop and mobile.
Sharesies
Shares, ETFs, Managed Funds, Index Funds
$0
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 8,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
OFFER
Tiger Brokers
Shares, ETFs, Options
$0
US, AU, Funds with exposure to multiple markets
Sign up to Tiger Brokers and get a free stock voucher worth NZ$10, plus receive 3 Rocket Lab shares and one lucky draw ticket to win a free share when you deposit at least NZ$500 into your Tiger account. Offer is for new clients only and is subject to minimum deposit requirements. T&Cs apply.
Trade shares in more than 7,000 companies across the US, Australia and Asia.
OFFER
Stake
Shares
$0
US
Sign up through Finder and use referral code "FINDERNZ" for a free stock valued up to US$150.
Trade more than 4,500 US-listed stocks and ETFs through Stake with $0 fees on trades.
loading

Compare up to 4 providers

Becton Dickinson shares at a glance

Information last updated 2021-09-24.
Open$253.22
High$254.61
Low$252.47
Close$253.18
Previous close$253.82
Change $-0.64
Change % -0.2521%
Volume 928,277
Information last updated 2022-06-20.
52-week range$221.19 - $276.35
50-day moving average $254.61
200-day moving average $250.48
Wall St. target price$284.45
PE ratio 37.1535
Dividend yield $3.4 (1.48%)
Earnings per share (TTM) $6.33

Becton Dickinson stock price (NYSE:BDX)

Use our graph to track the performance of BDX stocks over time.

Becton Dickinson price performance over time

Historical closes compared with the close of $253.18 from 2022-06-24

1 week (2022-06-17) 7.59%
1 month (2022-05-24) -1.66%
3 months (2022-03-23) -3.36%
6 months (2021-12-21) N/A
1 year (2021-06-25) 4.97%
2 years (2020-06-25) 10.59%
3 years (2019-06-25) 2.00%
5 years (2017-06-23) 33.16%

Is Becton Dickinson under- or over-valued?

Valuing Becton Dickinson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Becton Dickinson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Becton Dickinson's P/E ratio

Becton Dickinson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Becton Dickinson shares trade at around 37x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Becton Dickinson's PEG ratio

Becton Dickinson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.74. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Becton Dickinson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Becton Dickinson's EBITDA

Becton Dickinson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.2 billion.

The EBITDA is a measure of a Becton Dickinson's overall financial performance and is widely used to measure a its profitability.

Becton Dickinson financials

Revenue TTM $20 billion
Operating margin TTM 14.68%
Gross profit TTM $9.6 billion
Return on assets TTM 3.35%
Return on equity TTM 7.79%
Profit margin 9.59%
Book value $86.03
Market capitalisation $67.1 billion

TTM: trailing 12 months

Becton Dickinson's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Becton Dickinson.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Becton Dickinson's total ESG risk score

Total ESG risk: 33.76

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Becton Dickinson's overall score of 33.76 (as at 12/31/2018) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Becton Dickinson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Becton Dickinson's environmental score

Environmental score: 4.87/100

Becton Dickinson's environmental score of 4.87 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Becton Dickinson's social score

Social score: 20.06/100

Becton Dickinson's social score of 20.06 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Becton Dickinson's governance score

Governance score: 13.83/100

Becton Dickinson's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Becton Dickinson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Becton Dickinson's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Becton Dickinson scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Becton Dickinson hasn't always managed to keep its nose clean.

Becton Dickinson share dividends

28%

Dividend payout ratio: 27.78% of net profits

Recently Becton Dickinson has paid out, on average, around 27.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.48% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Becton Dickinson shareholders could enjoy a 1.48% return on their shares, in the form of dividend payments. In Becton Dickinson's case, that would currently equate to about $3.4 per share.

While Becton Dickinson's payout ratio might seem fairly standard, it's worth remembering that Becton Dickinson may be investing much of the rest of its net profits in future growth.

Becton Dickinson's most recent dividend payout was on 29 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 7 June 2022 (the "ex-dividend date").

Have Becton Dickinson's shares ever split?

Becton Dickinson's shares were split on a 1025:1000 basis on 31 March 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1025 shares. This wouldn't directly have changed the overall worth of your Becton Dickinson shares – just the quantity. However, indirectly, the new 2.4% lower share price could have impacted the market appetite for Becton Dickinson shares which in turn could have impacted Becton Dickinson's share price.

Becton Dickinson share price volatility

Over the last 12 months, Becton Dickinson's shares have ranged in value from as little as $221.1855 up to $276.3547. A popular way to gauge a stock's volatility is its "beta".

BDX.US volatility(beta: 0.66)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Becton Dickinson's is 0.6606. This would suggest that Becton Dickinson's shares are less volatile than average (for this exchange).

Becton Dickinson overview

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involve substantial risk of loss and therefore are not appropriate for all investors. Past performance is not an indication of future results. Consider your own circumstances and obtain your own advice before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use, Disclaimer & Privacy Policy.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site